• Colorectal cancer develops in the colon or rectum and often starts as precancerous polyps.

• Regular screening is essential for early detection and prevention.

• Treatment is tailored based on the cancer stage and may involve surgery, chemotherapy, or radiation.

• Prognosis improves significantly with early-stage diagnosis.

Types of Colorectal Cancer

Understanding the different types of colorectal cancer is essential for accurate diagnosis and treatment planning. When assessing what colon cancer looks like, doctors may identify growths that begin as benign polyps before turning malignant over time. Although rectal cancer and colon cancer share many similarities, they differ in location, surgical approach, and certain treatment strategies.

• Adenocarcinoma of the Colon: Represents over 90% of colorectal cancer cases; develops from gland-forming cells in the colon lining. Includes mucinous and signet-ring variants that may behave more aggressively.
• Neuroendocrine Tumors: Arise from hormone-producing cells in the colon; usually slow-growing but may spread to distant organs.
• Squamous Cell Carcinoma: Extremely rare in the colon and rectum. The term “squamous” is more commonly associated with anal cancer, which is a different entity with different standard treatment, so it should not be conflated with colorectal cancer.

Colorectal Cancer Signs & Symptoms

Recognizing the warning signs of colorectal cancer can lead to earlier diagnosis and better treatment outcomes. Many symptoms may seem mild at first, but noticing and reporting them promptly is important. Common signs include changes in bowel habits, such as ongoing diarrhea or constipation, and blood in the stool, which may sometimes be invisible to the eye. Other symptoms may include abdominal pain or cramping, unexplained weight loss, fatigue, or signs of bowel blockage like nausea and vomiting. Common symptoms include:

• Bowel changes: Persistent diarrhea, constipation, or narrower stools.
• Bleeding: Bright red or dark blood in stool, or anemia from hidden bleeding.
• General symptoms: Abdominal discomfort, tiredness, weight loss, or nausea.

Colorectal Cancer Stages

Colorectal cancer progresses through four distinct stages, each describing how far the disease has spread within the colon, rectum, or nearby organs. Accurate staging is critical because it determines the most effective treatment approach and helps predict long-term outcomes. Early stages are typically confined to the intestinal wall, while advanced stages may involve lymph nodes or distant metastases such as the liver or lungs. Staging is assessed using clinical imaging, pathology results, and surgical findings, following the TNM (Tumor, Node, Metastasis) classification system recommended by the American Joint Committee on Cancer (AJCC).

• Stage I: Tumor invades the submucosal or muscular layer without lymph node involvement.

• Stage II: Extension through the bowel wall but no spread to lymph nodes.

• Stage III: Involvement of regional lymph nodes.

• Stage IV: Metastatic spread to distant organs such as liver or lungs.

Survival Rate & Prognosis for Colorectal Cancer

According to SEER Cancer Statistics, about 37.1 new colorectal cancer cases occur per 100,000 people each year in the U.S., with a death rate of 12.9 per 100,000. The lifetime risk of diagnosis is roughly 3.9%. Over 1.4 million Americans are currently living with this cancer.

Colorectal cancer is the fourth most common cancer diagnosed. Five-year relative survival rates depend on the cancer stage at diagnosis, molecular tumor characteristics, and treatment efficacy. While advances in screening and treatment have improved outcomes, the rising incidence among younger adults underscores the urgent need for increased awareness and early prevention efforts.

Diagnosis & Screening of Colorectal Cancer

Providing clear information about what colorectal cancer is helps patients and caregivers make informed decisions. Medical consultation is recommended when symptoms like rectal bleeding, persistent bowel habit changes, or unexplained anemia arise. Screening protocols for average-risk adults begin at age 45 and include:

• Colonoscopy: The gold standard enabling visual inspection and polyp removal.

• Fecal Immunochemical Test (FIT): Detects hidden blood in stool samples.

• Stool DNA Tests: Identify DNA alterations linked to colorectal neoplasms.

• CT Colonography: A non-invasive imaging alternative.

Causes & Risk Factors of Colorectal Cancer

Colorectal cancer may develop through a combination of genetic, inflammatory, and lifestyle factors. The risk increases after age 45 and is higher in those with a family history, hereditary syndromes like Lynch or FAP, or chronic inflammatory bowel diseases. Unhealthy diets, obesity, smoking, alcohol use, and conditions such as type 2 diabetes further contribute to its development.

Key Risk Factors:

• Family or genetic predisposition: Lynch syndrome, FAP, and family history of CRC or polyps.
• Chronic inflammation: Long-standing ulcerative colitis or Crohn’s disease.
• Lifestyle and metabolic risks: Unhealthy diet, obesity, smoking, alcohol, type 2 diabetes, metabolic syndrome.

Colorectal Cancer Complications

Colorectal cancer often leads to serious complications, particularly in advanced stages. The disease frequently metastasizes to the liver and lungs, which significantly worsens prognosis. Locally, tumor growth can cause bowel obstruction or, less commonly, perforation, leading to peritonitis and sepsis. Chronic bleeding from the tumor can result in iron-deficiency anemia, affecting patient strength and recovery. Additionally, treatment-related complications such as chemotherapy-induced neuropathy and radiation enteritis may impair long-term quality of life. Postoperative complications like anastomotic leaks or strictures also require careful monitoring and management.

Other possible complications include:

• Tumor Growth and Spread: The cancer can block the bowel, causing pain, swelling, and constipation. It may also spread to organs like the liver and lungs.
• Bleeding and Anemia: Tumors can cause ongoing bleeding, which may lead to tiredness and weakness due to anemia.
• Treatment Side Effects: Chemotherapy, radiation, and surgery can cause nerve pain, bowel problems, or infections that affect recovery and quality of life.

Colorectal Cancer Treatment

Treatment for colorectal cancer (CRC) depends on the stage of the disease, overall health, and tumor location. Managing a tumor in the colon or neoplasm of the colon typically involves a combination of surgery, chemotherapy, targeted therapy, and, in certain cases, radiation therapy. Early detection of a mass in the colon significantly improves treatment success rates and long-term survival. Understanding key colon cancer facts, including treatment options, potential side effects, and recovery expectations, empowers patients to make informed choices and actively participate in their care.

While some individuals explore alternative or complementary therapies, these should only be used to support, not replace, evidence-based medical treatment. A multidisciplinary approach—guided by oncologists, surgeons, and nutrition specialists—offers the most effective path toward recovery, symptom control, and improved quality of life.

Colorectal Cancer Clinical Trials

Clinical trials for colorectal cancer are exploring new treatments that elevate the body’s ability to fight cancer. These include immunotherapies that help reactivate the immune system, particularly effective in patients with specific tumor types like those with certain genetic defects. Other trials focus on targeted therapies that block cancer growth by acting on specific gene mutations such as KRAS or BRAF. Additionally, advanced blood tests measuring circulating tumor DNA (ctDNA) are being used to monitor treatment response and detect cancer recurrence earlier.

• Immunotherapy: Treatments that boost the immune system to better recognize and destroy cancer cells.
• Targeted therapy: Drugs designed to attack cancer cells with specific genetic changes, improving treatment precision.
• Liquid biopsy (ctDNA): A blood test that helps track disease activity and guide treatment decisions in real time.